GINKGO BIOWORKS HOLDINGS INC (DNA) Stock Price & Overview
NYSE:DNA • US37611X2099
Current stock price
The current stock price of DNA is 6.87 USD. Today DNA is down by -0.43%. In the past month the price increased by 5.69%. In the past year, price decreased by -15.39%.
DNA Key Statistics
- Market Cap
- 404.78M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -5.64
- Dividend Yield
- N/A
DNA Stock Performance
DNA Stock Chart
DNA Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to DNA. When comparing the yearly performance of all stocks, DNA is a bad performer in the overall market: 85.51% of all stocks are doing better.
DNA Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to DNA. No worries on liquidiy or solvency for DNA as it has an excellent financial health rating, but there are worries on the profitability.
DNA Earnings
On February 26, 2026 DNA reported an EPS of -1.41 and a revenue of 33.40M. The company beat EPS expectations (4.05% surprise) and missed revenue expectations (-10.85% surprise).
DNA Forecast & Estimates
11 analysts have analysed DNA and the average price target is 10.2 USD. This implies a price increase of 48.47% is expected in the next year compared to the current price of 6.87.
For the next year, analysts expect an EPS growth of 28.19% and a revenue growth -7.98% for DNA
DNA Groups
Sector & Classification
DNA Financial Highlights
Over the last trailing twelve months DNA reported a non-GAAP Earnings per Share(EPS) of -5.64. The EPS increased by 36.91% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -27.93% | ||
| ROE | -61.5% | ||
| Debt/Equity | 0 |
DNA Ownership
DNA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 19.68 | 181.353B | ||
| DHR | DANAHER CORP | 22.62 | 135.856B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 135.09 | 44.438B | ||
| A | AGILENT TECHNOLOGIES INC | 17.16 | 32.454B | ||
| WAT | WATERS CORP | 20.93 | 29.831B | ||
| IQV | IQVIA HOLDINGS INC | 13.32 | 28.659B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 27.01 | 25.751B | ||
| ILMN | ILLUMINA INC | 24.41 | 19.531B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 31.7 | 18.514B | ||
| MEDP | MEDPACE HOLDINGS INC | 28.45 | 14.077B | ||
| RVTY | REVVITY INC | 16.02 | 9.874B | ||
| TEM | TEMPUS AI INC-CL A | N/A | 8.456B | ||
| TECH | BIO-TECHNE CORP | 24.18 | 8.417B |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About DNA
Company Profile
Ginkgo Bioworks Holdings, Inc. is a biotech company. The company is headquartered in Boston, Massachusetts and currently employs 485 full-time employees. The company went IPO on 2021-04-19. Its segments include Cell Engineering and Biosecurity. The Cell Engineering consists of research and development services performed under collaboration and license agreements relating to its cell programming platform. Its cell programming platform includes two core assets: the Foundry, and Codebase. The Biosecurity segment consists of biomonitoring and bioinformatics support services, offered to both government and non-government customers through its two core offerings: Canopy and Horizon. The firm provides comprehensive research and development services spanning the genetic medicine modalities: gene therapy, cell therapy and gene editing, and RNA therapeutics.
Company Info
IPO: 2021-04-19
GINKGO BIOWORKS HOLDINGS INC
27 Drydock Avenue, 8th Floor
Boston MASSACHUSETTS US
CEO: Harry E. Sloan
Employees: 485
Phone: 18774425362
GINKGO BIOWORKS HOLDINGS INC / DNA FAQ
What does GINKGO BIOWORKS HOLDINGS INC do?
Ginkgo Bioworks Holdings, Inc. is a biotech company. The company is headquartered in Boston, Massachusetts and currently employs 485 full-time employees. The company went IPO on 2021-04-19. Its segments include Cell Engineering and Biosecurity. The Cell Engineering consists of research and development services performed under collaboration and license agreements relating to its cell programming platform. Its cell programming platform includes two core assets: the Foundry, and Codebase. The Biosecurity segment consists of biomonitoring and bioinformatics support services, offered to both government and non-government customers through its two core offerings: Canopy and Horizon. The firm provides comprehensive research and development services spanning the genetic medicine modalities: gene therapy, cell therapy and gene editing, and RNA therapeutics.
What is the current price of DNA stock?
The current stock price of DNA is 6.87 USD. The price decreased by -0.43% in the last trading session.
What is the dividend status of GINKGO BIOWORKS HOLDINGS INC?
DNA does not pay a dividend.
What is the ChartMill rating of GINKGO BIOWORKS HOLDINGS INC stock?
DNA has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Can you provide the sector and industry classification for GINKGO BIOWORKS HOLDINGS INC?
GINKGO BIOWORKS HOLDINGS INC (DNA) operates in the Health Care sector and the Life Sciences Tools & Services industry.
When does GINKGO BIOWORKS HOLDINGS INC (DNA) report earnings?
GINKGO BIOWORKS HOLDINGS INC (DNA) will report earnings on 2026-05-07.